Brokers Offer Predictions for Haemonetics Co.'s Q1 2024 Earnings (NYSE:HAE)
Haemonetics Co. (NYSE:HAE – Get Rating) – Research analysts at Zacks Research increased their Q1 2024 EPS estimates for shares of Haemonetics in a research note issued on Friday, June 23rd. Zacks Research analyst R. Anand now anticipates that the medical instruments supplier will earn $0.74 per share for the quarter, up from their previous […]